Shougang Zhuang

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 17

Top Venues

FASEB journal : official publication of the Federation of American Societies for Experimental Biology

Journal of cellular and molecular medicine

The Journal of pathology

Clinical science (London, England : 1979)

Rhode Island Hospital, Brown University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Rhode Island Hospital, Brown University May 01 2014

United States

PI/Professor :: Medicine

Publications

Chao Yu, Jinhua Tang, Jianjun Yu, Yanjin Wang, Na Liu, Zheng Dong, Shougang Zhuang
JMJD3 activation contributes to renal protection and regeneration following acute kidney injury in mice. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 38 (7) (2024)
Chao Yu, Jinhua Tang, Jianjun Yu, Yanjin Wang, Na Liu, Zheng Dong, Shougang Zhuang
JMJD3 activation contributes to renal protection and regeneration following acute kidney injury in mice. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 38 (7) (2024)
Chao Yu, Tingting Li, Jialu Li, Binbin Cui, Na Liu, George Bayliss, Shougang Zhuang
Inhibition of polycomb repressive complex 2 by targeting EED protects against cisplatin-induced acute kidney injury. Journal of cellular and molecular medicine 26 (14) (2022)
Jianan Zou, Chao Yu, Chunyun Zhang, Yingjie Guan, Yunhe Zhang, Evelyn Tolbert, Wei Zhang, Ting Zhao, George Bayliss, Xiaogang Li, Zhibin Ye, Shougang Zhuang
Inhibition of MLL1-menin interaction attenuates renal fibrosis in obstructive nephropathy. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 37 (1) (2022)
Yingfeng Shi, Jinqing Li, Hui Chen, Yan Hu, Lunxian Tang, Yi Wang, Xiujuan Zang, Xiaoyan Ma, Guansen Huang, Xun Zhou, Min Tao, Zexin Lv, Si Chen, Andong Qiu, Shougang Zhuang, Na Liu
Inhibition of EZH2 suppresses peritoneal angiogenesis by targeting a VEGFR2/ERK1/2/HIF-1α-dependent signaling pathway. The Journal of pathology 258 (2) (2022)
Supaporn Kulthinee, Lijiang Wang, Naohiro Yano, Patrycja M Dubielecka, Ling X Zhang, Shougang Zhuang, Gangjian Qin, Yu Tina Zhao, Yue Eugene Chin, Ting C Zhao
Irisin Preserves Cardiac Performance and Insulin Sensitivity in Response to Hemorrhage. Pharmaceuticals (Basel, Switzerland) 15 (10) (2022)
Supaporn Kulthinee, Naohiro Yano, Shougang Zhuang, Lijiang Wang, Ting C Zhao
Critical Functions of Histone Deacetylases (HDACs) in Modulating Inflammation Associated with Cardiovascular Diseases. Pathophysiology : the official journal of the International Society for Pathophysiology 29 (3) (2022)
Jianan Zou, Chao Yu, Chunyun Zhang, Yingjie Guan, Yunhe Zhang, Evelyn Tolbert, Wei Zhang, Ting Zhao, George Bayliss, Xiaogang Li, Zhibin Ye, Shougang Zhuang
Inhibition of MLL1-menin interaction attenuates renal fibrosis in obstructive nephropathy. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 37 (1) (2022)
Feng Liu, Chao Yu, Huan Qin, Shenglei Zhang, Lu Fang, Yi Wang, Jun Wang, Binbin Cui, Susie Hu, Na Liu, Shougang Zhuang
Nintedanib attenuates peritoneal fibrosis by inhibiting mesothelial-to-mesenchymal transition, inflammation and angiogenesis. Journal of cellular and molecular medicine (2021)
Jianfeng Du, Yu Tina Zhao, Hao Wang, Ling X Zhang, Gangjian Qin, Shougang Zhuang, Marshall Edward Kadin, Y Eugene Chin, Paul Y Liu, Ting C Zhao
The Essential Role of PRAK in Preserving Cardiac Function and Insulin Resistance in High-Fat Diet-Induced Diabetes. International journal of molecular sciences 22 (15) (2021)
Guansen Huang, Yi Wang, Yingfeng Shi, Xiaoyan Ma, Min Tao, Xiujuan Zang, Yinghui Qi, Cheng Qiao, Lin Du, Lili Sheng, Shougang Zhuang, Na Liu
The prognosis and risk factors of baseline high peritoneal transporters on patients with peritoneal dialysis. Journal of cellular and molecular medicine 25 (18) (2021)
Hua Miao, Gang Cao, Xia-Qing Wu, Yuan-Yuan Chen, Dan-Qian Chen, Lin Chen, Nosratola D Vaziri, Ya-Long Feng, Wei Su, Yi Gao, Shougang Zhuang, Xiao-Yong Yu, Li Zhang, Yan Guo, Ying-Yong Zhao
Identification of endogenous 1-aminopyrene as a novel mediator of progressive chronic kidney disease via aryl hydrocarbon receptor activation. British journal of pharmacology 177 (15) (2020)
Zhaohui Ni, Haijiao Jin, Gengru Jiang, Niansong Wang, Ai Peng, Zhi-Yong Guo, Shou-Jun Bai, Rong Zhou, Jianrao Lu, Yi Wang, Ying Li, Shougang Zhuang, Chen Yu, Yueyi Deng, Hui Min Jin, Xudong Xu, Junli Zhang, Jun-Li Zhao, Xiuzhi Yu, Xiao-Xia Wang, Liming Zhang, Jianying Niu, Kun Liu, Xiaorong Bao, Qin Wang, Jun Ma, Chun Hu, Xiujuan Zang, Qing Yu
A Telemedicine-Based Registration System for the Management of Renal Anemia in Patients on Maintenance Hemodialysis: Multicenter Study. Journal of medical Internet research 21 (5) (2019)
Feng Liu, George Bayliss, Shougang Zhuang
Application of nintedanib and other potential anti-fibrotic agents in fibrotic diseases. Clinical science (London, England : 1979) 133 (12) (2019)
Jinhua Tang, Shougang Zhuang
Histone acetylation and DNA methylation in ischemia/reperfusion injury. Clinical science (London, England : 1979) 133 (4) (2019)
Yingfeng Shi, Min Tao, Yi Wang, Xiujuan Zang, Xiaoyan Ma, Andong Qiu, Shougang Zhuang, Na Liu
Genetic or pharmacologic blockade of enhancer of zeste homolog 2 inhibits the progression of peritoneal fibrosis. The Journal of pathology 250 (1) (2019)
Na Liu, Liuqing Xu, Yingfeng Shi, Shougang Zhuang
Podocyte Autophagy: A Potential Therapeutic Target to Prevent the Progression of Diabetic Nephropathy. Journal of diabetes research 2017 (2017)

Shougang Zhuang.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Shougang Zhuang